ProMIS Neurosciences, Inc. (PMN)

NCM – Real Time Price. Currency in USD

14.39

-0.58 (-3.91%)

Market open: Aug 12, 2026, 2:05 PM EDT

14.41

-0.56 (-3.74%)

Previous after-hours: Aug 11, 2026, 5:12 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

03.08.2026

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026.

Videos

No Data

There is no data to display

ProMIS Neurosciences, Inc. (PMN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videos

No Data

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videos

No Data

Search stocks

ProMIS Neurosciences, Inc. (PMN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videos

No Data

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Videos

No Data